Home/Filings/4/0001628280-25-025244
4//SEC Filing

Scherman Jeffrey J 4

Accession 0001628280-25-025244

CIK 0001671284other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 6:06 PM ET

Size

7.3 KB

Accession

0001628280-25-025244

Insider Transaction Report

Form 4
Period: 2025-05-09
Scherman Jeffrey J
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-05-09+34112,575 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-05-093410 total
    Common Stock (341 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]These restricted stock units vested over three years as follows: (a) one-third of the original grant amount vested on May 9, 2023, (b) one-third of the original grant amount vested on May 9, 2024, (c) and one-third of the original grant amount vested on May 9, 2025.

Issuer

NeueHealth, Inc.

CIK 0001671284

Entity typeother

Related Parties

1
  • filerCIK 0001867147

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:06 PM ET
Size
7.3 KB